GlassScriptPhysician profile
Nadia Nikoueiha
NPI 1629694682
$5,126.76
in general payments reported to CMS, 2019-2025
25 companies · $536 in 2025
The $536 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $172 · 2021: $321 · 2022: $394 · 2023: $1,494 · 2024: $2,210 · 2025: $536.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,327 · Travel and Lodging: $1,913.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,326.89 |
| Travel and Lodging | $1,912.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $1,610.76 | 2023-2024 | |
| Stryker Corporation | $1,256.04 | 2020-2025 | Prostep, Prophecy, Charlotte |
| Depuy Synthes Sales INC. | $301.96 | 2020-2023 | Dynaforce |
| Next Science LLC | $282.66 | 2020-2024 | Surgx, Blastx, Xperience |
| Organogenesis INC. | $279.13 | 2022-2024 | |
| Abbvie INC. | $210.36 | 2021-2025 | |
| Smith+Nephew, INC. | $188.23 | 2024-2025 | Evos, Grafix Pl, Bone Anchors With Arthroscopic Delivery System |
| Imbed Biosciences INC. | $163.46 | 2023 | |
| Paratek Pharmaceuticals, INC. | $156.84 | 2020-2025 | Nuzyra |
| Treace Medical Concepts, INC. | $121.40 | 2023 | Lapiplasty System |
| Fusion Orthopedics USA, LLC | $108.35 | 2025 | |
| Zimmer Biomet Holdings, INC. | $82.77 | 2020-2021 | |
| Integra Lifesciences Corporation | $47.72 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Solventum Corporation | $44.93 | 2024-2025 | Activ.A.C. |
| Bioventus LLC | $31.47 | 2025 | Exogen Ultrasound Bone Healing System |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Piedmont Plus Innovation | $31.08 | 2024-2025 | |
| Kerecis Limited | $30.31 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| In2bones USA, LLC | $29.67 | 2021 | |
| Orthofix Medical, INC. | $26.26 | 2024-2025 | Physio-Stim, Accelstim |
| Highridge Medical LLC | $24.06 | 2024 | Biomet Ebi Bone Healing System |
| Vertex Pharmaceuticals Incorporated | $23.91 | 2025 | |
| Globus Medical, INC. | $22.73 | 2025 | Senza |
| Abbott Laboratories | $19.91 | 2025 | Eterna |
| Inari Medical, INC. | $16.43 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Averitas Pharma INC. | $16.32 | 2024 | Qutenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nadia Nikoueiha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.